Pharmacology and Therapeutic Potential of Sigma1 Receptor Ligands

Sigma (σ) receptors, initially described as a subtype of opioid receptors, are now considered unique receptors. Pharmacological studies have distinguished two types of σ receptors, termed σ1 and σ2. Of these two subtypes, the σ1 receptor has been cloned in humans and rodents, and its amino acid sequence shows no homology with other mammalian proteins. Several psychoactive drugs show high to moderate affinity for σ1 receptors, including the antipsychotic haloperidol, the antidepressant drugs fluvoxamine and sertraline, and the psychostimulants cocaine and methamphetamine; in addition, the anticonvulsant drug phenytoin allosterically modulates σ1 receptors. Certain neurosteroids are known to interact with σ1 receptors, and have been proposed to be their endogenous ligands. These receptors are located in the plasma membrane and in subcellular membranes, particularly in the endoplasmic reticulum, where they play a modulatory role in intracellular Ca2+ signaling. Sigma1 receptors also play a modulatory role in the activity of some ion channels and in several neurotransmitter systems, mainly in glutamatergic neurotransmission. In accordance with their widespread modulatory role, σ1 receptor ligands have been proposed to be useful in several therapeutic fields such as amnesic and cognitive deficits, depression and anxiety, schizophrenia, analgesia, and against some effects of drugs of abuse (such as cocaine and methamphetamine). In this review we provide an overview of the present knowledge of σ1 receptors, focussing on σ1 ligand neuropharmacology and the role of σ1 receptors in behavioral animal studies, which have contributed greatly to the potential therapeutic applications of σ1 ligands

An Indication of Anisotropy in Arrival Directions of Ultra-high-energy Cosmic Rays through Comparison to the Flux Pattern of Extragalactic Gamma-Ray Sources

A new analysis of the data set from the Pierre Auger Observatory provides evidence for anisotropy in the arrival directions of ultra-high-energy cosmic rays on an intermediate angular scale, which is indicative of excess arrivals from strong, nearby sources. The data consist of 5514 events above 20 EeV with zenith angles up to 80 degrees. recorded before 2017 April 30. Sky models have been created for two distinct populations of extragalactic gamma-ray emitters: active galactic nuclei from the second catalog of hard Fermi-LAT sources (2FHL) and starburst galaxies from a sample that was examined with Fermi-LAT. Flux-limited samples, which include all types of galaxies from the Swift-BAT and 2MASS surveys, have been investigated for comparison. The sky model of cosmic-ray density constructed using each catalog has two free parameters, the fraction of events correlating with astrophysical objects, and an angular scale characterizing the clustering of cosmic rays around extragalactic sources. A maximum-likelihood ratio test is used to evaluate the best values of these parameters and to quantify the strength of each model by contrast with isotropy. It is found that the starburst model fits the data better than the hypothesis of isotropy with a statistical significance of 4.0 sigma, the highest value of the test statistic being for energies above 39 EeV. The three alternative models are favored against isotropy with 2.7 sigma-3.2 sigma significance. The origin of the indicated deviation from isotropy is examined and prospects for more sensitive future studies are discussed

Inferences on mass composition and tests of hadronic interactions from 0.3 to 100 EeV using the water-Cherenkov detectors of the Pierre Auger Observatory

We present a new method for probing the hadronic interaction models at ultrahigh energy and extracting details about mass composition. This is done using the time profiles of the signals recorded with the water-Cherenkov detectors of the Pierre Auger Observatory. The profiles arise from a mix of the muon and electromagnetic components of air showers. Using the risetimes of the recorded signals, we define a new parameter, which we use to compare our observations with predictions from simulations. We find, first, inconsistencies between our data and predictions over a greater energy range and with substantially more events than in previous studies. Second, by calibrating the new parameter with fluorescence measurements from observations made at the Auger Observatory, we can infer the depth of shower maximum Xmax for a sample of over 81,000 events extending from 0.3 to over 100 EeV. Above 30 EeV, the sample is nearly 14 times larger than what is currently available from fluorescence measurements and extending the covered energy range by half a decade. The energy dependence of ?Xmaxcopyright is compared to simulations and interpreted in terms of the mean of the logarithmic mass. We find good agreement with previous work and extend the measurement of the mean depth of shower maximum to greater energies than before, reducing significantly the statistical uncertainty associated with the inferences about mass composition

Inflammation-induced Decrease In Voluntary Wheel Running In Mice: A Nonreflexive Test For Evaluating Inflammatory Pain And Analgesia

Inflammatory pain impacts adversely on the quality of life of patients, often resulting in motor disabilities. Therefore, we studied the effect of peripheral inflammation induced by intraplantar administration of complete Freund's adjuvant (CFA) in mice on a particular form of voluntary locomotion, wheel running, as an index of mobility impairment produced by pain. The distance traveled over 1 hour of free access to activity wheels decreased significantly in response to hind paw inflammation, peaking 24 hours after CFA administration. Recovery of voluntary wheel running by day 3 correlated with the ability to support weight on the inflamed limb. Inflammation-induced mechanical hypersensitivity, measured with von Frey hairs, lasted considerably longer than the impaired voluntary wheel running and is not driving; therefore, the change in voluntary behavior. The CFA-induced decrease in voluntary wheel running was dose-dependently reversed by subcutaneous administration of antiinflammatory and analgesic drugs, including naproxen (10-80 mg/kg), ibuprofen (2.5-20 mg/kg), diclofenac (1.25-10 mg/kg), celecoxib (2.5-20 mg/kg), prednisolone (0.62-5 mg/kg), and morphine (0.06-0.5 mg/kg), all at much lower doses than reported in most rodent models. Furthermore, the doses that induced recovery in voluntary wheel running did not reduce CFA-induced mechanical allodynia, indicating a greater sensitivity of the former as a surrogate measure of inflammatory pain. We conclude that monitoring changes in voluntary wheel running in mice during peripheral inflammation is a simple, observer-independent objective measure of functional changes produced by inflammation, likely more aligned to the global level of pain than reflexive measures, and much more sensitive to analgesic drug effects. © 2011 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.1534876884Andrews, N., Legg, E., Lisak, D., Issop, Y., Richardson, D., Harper, S., Huang, W., Rice, A.S., Spontaneous burrowing behaviour in the rat is reduced by peripheral nerve injury or inflammation associated pain (2011) Eur J Pain, , [Epub ahead of print]Blackburn-Munro, G., Pain-like behaviours in animals - How human are they? (2004) Trends in Pharmacological Sciences, 25 (6), pp. 299-305. , DOI 10.1016/j.tips.2004.04.008, PII S0165614704001208Boyce-Rustay, J.M., Zhong, C., Kohnken, R., Baker, S.J., Simler, G.H., Wensink, E.J., Decker, M.W., Honore, P., Comparison of mechanical allodynia and the affective component of inflammatory pain in rats (2010) Neuropharmacology, 58, pp. 537-543Chesler, E.J., Wilson, S.G., Lariviere, W.R., Rodriguez-Zas, S.L., Mogil, J.S., Identification and ranking of genetic and laboratory environment factors influencing a behavioral trait, thermal nociception, via computational analysis of a large data archive (2002) Neuroscience and Biobehavioral Reviews, 26 (8), pp. 907-923. , DOI 10.1016/S0149-7634(02)00103-3, PII S0149763402001033Chesler, E.J., Wilson, S.G., Rodriguez-Zas, S.L., Mogil, J.S., Influences of laboratory environment on behavior (2002) Nat Neurosci, 5, pp. 1101-1102Colpaert, F.C., Tarayre, J.P., Alliaga, M., Bruins Slot, L.A., Attal, N., Koek, W., Opiate self-administration as a measure of chronic nociceptive pain in arthritic rats (2001) Pain, 91 (1-2), pp. 33-45. , DOI 10.1016/S0304-3959(00)00413-9, PII S0304395900004139Doyle, G., Jayawardena, S., Ashraf, E., Cooper, S.A., Efficacy and tolerability of nonprescription Ibuprofen versus Celecoxib for dental pain (2002) Journal of Clinical Pharmacology, 42 (8), pp. 912-919. , DOI 10.1177/009127002401102830El Yacoubi, M., Ledent, C., Parmentier, M., Costentin, J., Vaugeois, J.-M., The anxiogenic-like effect of caffeine in two experimental procedures measuring anxiety in the mouse is not shared by selective A(2A) adenosine receptor antagonists (2000) Psychopharmacology, 148 (2), pp. 153-163Elhabazi, K., Trigo, J., Mollereau, C., Moulédous, L., Zajac, J.M., Bihel, F., Schmitt, M., Simonin, F., Involvement of neuropeptide FF receptors in neuroadaptative responses to acute and chronic opiate treatments (2012) Br J Pharmacol, 165, pp. 424-443Gabriel, A.F., Marcus, M.A.E., Honig, W.M.M., Walenkamp, G.H.I.M., Joosten, E.A.J., The CatWalk method: A detailed analysis of behavioral changes after acute inflammatory pain in the rat (2007) Journal of Neuroscience Methods, 163 (1), pp. 9-16. , DOI 10.1016/j.jneumeth.2007.02.003, PII S0165027007000660Gøtzsche, P.C., Johansen, H.K., Short-term low-dose corticosteroids vs placebo and nonsteroidal anti-inflammatory drugs in rheumatoid arthritis (2009) Cochrane Database Syst Rev, 1, p. 000189Gutierrez, T., Crystal, J.D., Zvonok, A.M., Makriyannis, A., Hohmann, A.G., Self-medication of a cannabinoid CB2 agonist in an animal model of neuropathic pain (2011) Pain, 152, pp. 1976-1987Hinman, R.S., Bennell, K.L., Crossley, K.M., McConnell, J., Immediate effects of adhesive tape on pain and disability in individuals with knee osteoarthritis (2003) Rheumatology, 42 (7), pp. 865-869. , DOI 10.1093/rheumatology/keg233Hunskaar, S., Hole, K., The formalin test in mice: Dissociation between inflammatory and non-inflammatory pain (1987) Pain, 30 (1), pp. 103-114. , DOI 10.1016/0304-3959(87)90088-1Huntjens, D.R., Spalding, D.J., Danhof, M., Della Pasqua, O.E., Differences in the sensitivity of behavioural measures of pain to the selectivity of cyclo-oxygenase inhibitors (2009) Eur J Pain, 13, pp. 448-457Insel, P.A., Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment of gout (1996) The Pharmacological Basis of Therapeutics, pp. 617-657. , J.G. Hardman, L.E. Limbird, P.B. Molinoff, R.W. Ruddon, Gilman A. Goodman, McGraw-Hill New YorkJanssens, H.J., Janssen, M., Van De Lisdonk, E.H., Van Riel, P.L., Van Weel, C., Use of oral prednisolone or naproxen for the treatment of gout arthritis: A double-blind, randomised equivalence trial (2008) The Lancet, 371 (9627), pp. 1854-1860. , DOI 10.1016/S0140-6736(08)60799-0, PII S0140673608607990Jones, C.K., Peters, S.C., Shannon, H.E., Efficacy of duloxetine, a potent and balanced serotonergic and noradrenergic reuptake inhibitor, in inflammatory and acute pain models in rodents (2005) Journal of Pharmacology and Experimental Therapeutics, 312 (2), pp. 726-732. , DOI 10.1124/jpet.104.075960Kuphal, K.E., Fibuch, E.E., Taylor, B.K., Extended swimming exercise reduces inflammatory and peripheral neuropathic pain in rodents (2007) Journal of Pain, 8 (12), pp. 989-997. , DOI 10.1016/j.jpain.2007.08.001, PII S1526590007008140Labuda, C.J., Fuchs, P.N., Low dose aspirin attenuates escape/avoidance behavior, but does not reduce mechanical hyperalgesia in a rodent model of inflammatory pain (2001) Neuroscience Letters, 304 (3), pp. 137-140. , DOI 10.1016/S0304-3940(01)01787-6, PII S0304394001017876Malmstrom, K., Daniels, S., Kotey, P., Seidenberg, B.C., Desjardins, P.J., Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain: A randomized, placebo- and active-comparator- controlled clinical trial (1999) Clinical Therapeutics, 21 (10), pp. 1653-1663. , DOI 10.1016/S0149-2918(99)80045-9Martin, T.J., Zhang, Y., Buechler, N., Conklin, D.R., Eisenach, J.C., Intrathecal morphine and ketorolac analgesia after surgery: Comparison of spontaneous and elicited responses in rats (2005) Pain, 113 (3), pp. 376-385. , DOI 10.1016/j.pain.2004.11.017, PII S0304395904005548Matson, D.J., Broom, D.C., Carson, S.R., Baldassari, J., Kehne, J., Cortright, D.N., Inflammation-induced reduction of spontaneous activity by adjuvant: A novel model to study the effect of analgesics in rats (2007) Journal of Pharmacology and Experimental Therapeutics, 320 (1), pp. 194-201. , http://jpet.aspetjournals.org/cgi/reprint/320/1/194, DOI 10.1124/jpet.106.109736Mogil, J.S., Animal models of pain: Progress and challenges (2009) Nat Rev Neurosci, 10, pp. 283-294Mogil, J.S., Davis, K.D., Derbyshire, S.W., The necessity of animal models in pain research (2010) Pain, 151, pp. 12-17Mogil, J.S., Graham, A.C., Ritchie, J., Hughes, S.F., Austin, J.S., Schorscher-Petcu, A., Langford, D.J., Bennett, G.J., Hypolocomotion, asymmetrically directed behaviors (licking, lifting, flinching, and shaking) and dynamic weight bearing (gait) changes are not measures of neuropathic pain in mice (2010) Mol Pain, 6, p. 34Nagakura, Y., Okada, M., Kohara, A., Kiso, T., Toya, T., Iwai, A., Wanibuchi, F., Yamaguchi, T., Allodynia and hyperalgesia in adjuvant-induced arthritic rats: Time course of progression and efficacy of analgesics (2003) Journal of Pharmacology and Experimental Therapeutics, 306 (2), pp. 490-497. , DOI 10.1124/jpet.103.050781Nieto, F.R., Entrena, J.M., Cendan, C.M., Pozo, E.D., Vela, J.M., Baeyens, J.M., Tetrodotoxin inhibits the development and expression of neuropathic pain induced by paclitaxel in mice (2008) Pain, 137 (3), pp. 520-531. , DOI 10.1016/j.pain.2007.10.012, PII S0304395907005799Ortiz, M.I., Blockade of the antinociception induced by diclofenac, but not of indomethacin, by sulfonylureas and biguanides (2011) Pharmacol Biochem Behav, 99, pp. 1-6Patel, S., Naeem, S., Kesingland, A., Froestl, W., Capogna, M., Urban, L., Fox, A., The effects of GABA B agonists and gabapentin on mechanical hyperalgesia in models of neuropathic and inflammatory pain in the rat (2001) Pain, 90 (3), pp. 217-226. , DOI 10.1016/S0304-3959(00)00404-8, PII S0304395900004048Rice, A.S., Cimino-Brown, D., Eisenach, J.C., Kontinen, V.K., Lacroix-Fralish, M.L., MacHin, I., Mogil, J.S., Stöhr, T., Animal models and the prediction of efficacy in clinical trials of analgesic drugs: A critical appraisal and call for uniform reporting standards (2008) Pain, 139, pp. 243-247Sahin, N.O., Librowski, T., Investigations of anti-inflammatory and analgesic activities of prednisolone solid dispersion prepared with skimmed milk (2003) Polish Journal of Pharmacology, 55 (2), pp. 261-265Sanchez, K., Papelard, A., Nguyen, C., Bendeddouche, I., Jousse, M., Rannou, F., Revel, M., Poiraudeau, S., McMaster-Toronto arthritis patient preference disability questionnaire sensitivity to change in low back pain: Influence of shifts in priorities (2011) PLoS One, 6, p. 20274Sherwin, C.M., Voluntary wheel running: A review and novel interpretation (1998) Animal Behaviour, 56 (1), pp. 11-27. , DOI 10.1006/anbe.1998.0836Smith, G.D., Harrison, S.M., Birch, P.J., Elliott, P.J., Malcangio, M., Bowery, N.G., Increased sensitivity to the antinociceptive activity of (±)-Baclofen in an animal model of chronic neuropathic, but not chronic inflammatory hyperalgesia (1994) Neuropharmacology, 33 (9), pp. 1103-1108. , DOI 10.1016/0028-3908(94)90149-XStevenson, G.W., Cormier, J., Mercer, H., Adams, C., Dunbar, C., Negus, S.S., Bilsky, E.J., Targeting pain-depressed behaviors in preclinical assays of pain and analgesia: Drug effects on acetic acid-depressed locomotor activity in ICR mice (2009) Life Sci, 85, pp. 309-315Stevenson, G.W., Mercer, H., Cormier, J., Dunbar, C., Benoit, L., Adams, C., Jezierski, J., Bilsky, E.J., Monosodium iodoacetate-induced osteoarthritis produces pain-depressed wheel running in rats: Implications for preclinical behavioral assessment of chronic pain (2011) Pharmacol Biochem Behav, 98, pp. 35-42Tegeder, I., Niederberger, E., Vetter, G., Brautigam, L., Geisslinger, G., Effects of selective COX-1 and -2 inhibition on formalin-evoked nociceptive behaviour and prostaglandin E 2 release in the spinal cord (2001) Journal of Neurochemistry, 79 (4), pp. 777-786. , DOI 10.1046/j.1471-4159.2001.00613.xTétreault, P., Dansereau, M.A., Doré-Savard, L., Beaudet, N., Sarret, P., Weight bearing evaluation in inflammatory, neuropathic and cancer chronic pain in freely moving rats (2011) Physiol Behav, 104, pp. 495-502Urban, R., Scherrer, G., Goulding, E.H., Tecott, L.H., Basbaum, A.I., Behavioral indices of ongoing pain are largely unchanged in male mice with tissue or nerve injury-induced mechanical hypersensitivity (2011) Pain, 152, pp. 990-1000Verhoeven, A.C., Boers, M., Van Der Liden, S., Validity of the MACTAR questionnaire as a functional index in a rheumatoid arthritis clinical trial. The McMaster Toronto Arthritis (2000) J Rheumatol, 27, pp. 2801-2809Vierck, C.J., Acosta-Rua, A.J., Johnson, R.D., Bilateral chronic constriction of the sciatic nerve: A model of long-term cold hyperalgesia (2005) Journal of Pain, 6 (8), pp. 507-517. , DOI 10.1016/j.jpain.2005.03.003, PII S1526590005005341Vierck, C.J., Hansson, P.T., Yezierski, R.P., Clinical and pre-clinical pain assessment: Are we measuring the same thing? (2008) Pain, 135, pp. 7-10Vierck Jr., C.J., Kline IV, R.H., Wiley, R.G., Intrathecal substance P-saporin attenuates operant escape from nociceptive thermal stimuli (2003) Neuroscience, 119 (1), pp. 223-232. , DOI 10.1016/S0306-4522(03)00125-8Villanueva, L., Is there a gap between preclinical and clinical studies of analgesia? (2000) Trends Pharmacol Sci, 21, pp. 461-462. , author reply 465Waldhoer, M., Bartlett, S.E., Whistler, J.L., Opioid receptors (2004) Annual Review of Biochemistry, 73, pp. 953-990. , DOI 10.1146/annurev.biochem.73.011303.073940Whiteside, G.T., Harrison, J., Boulet, J., Mark, L., Pearson, M., Gottshall, S., Walker, K., Pharmacological characterisation of a rat model of incisional pain (2004) British Journal of Pharmacology, 141 (1), pp. 85-91. , DOI 10.1038/sj.bjp.0705568Yashpal, K., Coderre, T.J., Influence of formalin concentration on the antinociceptive effects of anti-inflammatory drugs in the formalin test in rats: Separate mechanisms underlying the nociceptive effects of low- and high-concentration formalin (1998) European Journal of Pain, 2 (1), pp. 63-68. , DOI 10.1016/S1090-3801(98)90047-7Zimmermann, M., Ethical guidelines for investigations of experimental pain in conscious animals (1983) Pain, 16 (2), pp. 109-110. , DOI 10.1016/0304-3959(83)90201-

Next-generation sequencing of microRNAs uncovers expression signatures in polarized macrophages

microRNAs (miRNAs) are small noncoding RNAs that regulate gene expression at a posttranscriptional level and play a crucial role in the development of cells of the immune system. Macrophages are essential for generating inflammatory reactions upon tissue damage and encountering of invading pathogens, yet modulation of their immune responses is critical for maintaining tissue homeostasis. Macrophages can present different phenotypes, depending on the cytokine environment they encounter in the affected tissues. In this study, we have identified expression signatures of miRNAs that are differentially regulated during maturation of monocytes and polarization of macrophages by cytokines. We present a comprehensive characterization of miRNA expression in human monocytes and M1, M2a, and M2c polarized macrophages, using next-generation sequencing. Furthermore, we show that miRNA expression signatures are closely related to the various immune functions of polarized macrophages and therefore are involved in shaping the diverse phenotypes of these cells. The miRNAs identified here serve as markers for identification of inflammatory macrophages involved in the development of immune responses. Our findings contribute to understanding the role of miRNAs in determining the macrophage function in healthy and diseased tissues

Biotechnology approaches to overcome biotic and abiotic stress constraints in legumes

Biotic and abiotic stresses cause significant yield losses in legumes and can significantly affect their productivity. Biotechnology tools such as marker-assisted breeding, tissue culture, in vitro mutagenesis and genetic transformation can contribute to solve or reduce some of these constraints. However, only limited success has been achieved so far. The emergence of “omic” technologies and the establishment of model legume plants such as Medicago truncatula and Lotus japonicus are promising strategies for understanding the molecular genetic basis of stress resistance, which is an important bottleneck for molecular breeding. Understanding the mechanisms that regulate the expression of stress-related genes is a fundamental issue in plant biology and will be necessary for the genetic improvement of legumes. In this review, we describe the current status of biotechnology approaches in relation to biotic and abiotic stresses in legumes and how these useful tools could be used to improve resistance to important constraints affecting legume crops.E. Prats is funded by an European Marie Curie Reintegration Grant, N. Rispail by (FP5) Eufaba project. Our work in this area is supported by Spanish CICYT project AGL-2002-03248 and European Union project FP6-2002-FOOD-1-506223. K. Singh’s work in this area is supported in part by the Grains Research and Development Corporation (GRDC) and the Department of Education, Science and Training (DEST) in Australia.Peer reviewe